BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 2407766)

  • 1. Magnesium bioavailability from magnesium citrate and magnesium oxide.
    Lindberg JS; Zobitz MM; Poindexter JR; Pak CY
    J Am Coll Nutr; 1990 Feb; 9(1):48-55. PubMed ID: 2407766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model system for assessing physicochemical factors affecting calcium absorbability from the intestinal tract.
    Pak CY; Poindexter J; Finlayson B
    J Bone Miner Res; 1989 Feb; 4(1):119-27. PubMed ID: 2718774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate.
    Koenig K; Padalino P; Alexandrides G; Pak CY
    J Urol; 1991 Feb; 145(2):330-4. PubMed ID: 1988724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: changes produced by food-magnesium interaction.
    Lindberg J; Harvey J; Pak CY
    J Urol; 1990 Feb; 143(2):248-51. PubMed ID: 2299712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of bioavailability of Mg from Mg citrate and Mg oxide by measuring urinary excretion in Mg-saturated subjects.
    Werner T; Kolisek M; Vormann J; Pilchova I; Grendar M; Struharnanska E; Cibulka M
    Magnes Res; 2019 Aug; 32(3):63-71. PubMed ID: 32162607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced calcium bioavailability from a solubilized form of calcium citrate.
    Pak CY; Harvey JA; Hsu MC
    J Clin Endocrinol Metab; 1987 Oct; 65(4):801-5. PubMed ID: 3654922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium bioavailability from calcium carbonate and calcium citrate.
    Nicar MJ; Pak CY
    J Clin Endocrinol Metab; 1985 Aug; 61(2):391-3. PubMed ID: 4008614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citraturic response to oral citric acid load.
    Sakhaee K; Alpern R; Poindexter J; Pak CY
    J Urol; 1992 Apr; 147(4):975-6. PubMed ID: 1552616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of citrate from two different preparations of potassium citrate.
    Harvey JA; Zobitz MM; Pak CY
    J Clin Pharmacol; 1989 Apr; 29(4):338-41. PubMed ID: 2723122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
    Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K
    Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal citrate absorption in nephrolithiasis.
    Fegan J; Khan R; Poindexter J; Pak CY
    J Urol; 1992 May; 147(5):1212-4. PubMed ID: 1569651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of US commercial magnesium preparations.
    Firoz M; Graber M
    Magnes Res; 2001 Dec; 14(4):257-62. PubMed ID: 11794633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal absorption of Ca(H2PO4)2 and Ca citrate compared by two methods.
    Schuette SA; Knowles JB
    Am J Clin Nutr; 1988 May; 47(5):884-8. PubMed ID: 3364403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans.
    Easom JM; Caraccio TR; Lovejoy FH
    Clin Pharm; 1982; 1(2):154-6. PubMed ID: 7185512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of calcium carbonate, magnesium oxide and sodium citrate bicarbonate health supplements on the urinary risk factors for kidney stone formation.
    Allie S; Rodgers A
    Clin Chem Lab Med; 2003 Jan; 41(1):39-45. PubMed ID: 12636048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate.
    Harvey JA; Zobitz MM; Pak CY
    J Bone Miner Res; 1988 Jun; 3(3):253-8. PubMed ID: 3213620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium bioavailability after administration of sucrosomial® magnesium: results of an ex-vivo study and a comparative, double-blinded, cross-over study in healthy subjects.
    Brilli E; Khadge S; Fabiano A; Zambito Y; Williams T; Tarantino G
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1843-1851. PubMed ID: 29630135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study.
    Walker AF; Marakis G; Christie S; Byng M
    Magnes Res; 2003 Sep; 16(3):183-91. PubMed ID: 14596323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bioavailability of 26Al-labelled aluminium citrate and aluminium hydroxide in volunteers.
    Priest ND; Talbot RJ; Austin JG; Day JP; King SJ; Fifield K; Cresswell RG
    Biometals; 1996 Jul; 9(3):221-8. PubMed ID: 8696074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of magnesium diglycinate vs magnesium oxide in patients with ileal resection.
    Schuette SA; Lashner BA; Janghorbani M
    JPEN J Parenter Enteral Nutr; 1994; 18(5):430-5. PubMed ID: 7815675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.